Nexstim Plc12.09.2016 11:00:00 CET
Company announcement, Helsinki, 12 September 2016 at 12:00 pm
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that it has concluded the co-operation negotiations which started 22 August 2016 with its personnel representatives. As a conclusion, a maximum of 2 employment agreements will be terminated and the maximum of 2 people will be permanently laid off and one person will be working part time in the future.
The negotiations concerned the whole personnel in Finland and are now concluded.
NEXSTIM PLC
Martin Jamieson, Chairman and CEO
For further information, please visit www.nexstim.com or contact:
Nexstim +44 771 516 3942
Martin Jamieson, Chairman and CEO martin.jamieson@nexstim.com
UB Securities Ltd (Certified Adviser) +358 (0)9 2538 0246
Consilium Strategic Communications +44 (0)20 3709 5700
Mary-Jane Elliott / Ivar Milligan / Laura Thornton nexstim@consilium-comms.com
About Nexstim Plc
Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBTŪ) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com